Wilson Sonsini advised ArrePath on the deal.ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing to…
ArrePath’s $20 Million Seed Financing
Wilson Sonsini advised ArrePath on the deal.ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing to…